Almeida Andrea A, Wojt Aika, Metayer Catherine, Kanetsky Peter A, Graubard Barry I, Alvarez Christian S, McGlynn Katherine A
Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
Cancer. 2025 Jan 15;131(2):e35706. doi: 10.1002/cncr.35706.
Testicular germ cell tumors (TGCTs) are the most common cancers among young men in the United States. Incidence rates among non-Hispanic White (NHW) men historically have been much higher than the rates among other men. To study whether this pattern had changed, the authors examined trends in TGCT incidence for the years 1992-2021.
By using the Surveillance, Epidemiology, and End Results 12 registries database, age-standardized incidence rates per 100,000 person-years and 95% confidence intervals (CIs) were calculated overall and by histologic type (seminoma and nonseminoma), age, stage at diagnosis, and race/ethnicity. Trends in 5-year survival also were examined.
The age-standardized incidence rate of TGCT per 100,000 person-years increased from 4.71 (95% CI, 4.39-5.05) in 1992 to 6.22 (95% CI, 5.88-6.58) in 2021. The rates increased for both seminoma (average annual percent change [AAPC], 0.57%; 95% CI, 0.40%-0.75%) and nonseminoma (AAPC, 1.41%; 95% CI, 1.17%-1.64%) and among all race/ethnic groups, although the rates stabilized among NHW men. Increases in incidence were greatest among Hispanic men (AAPC, 3.03%; 95% CI, 2.66%-3.40%), who had one of the youngest median ages at diagnosis and were more likely to be diagnosed at advanced stages compared with NHW men. Seminoma and nonseminoma rates among Hispanic men converged over the study period, whereas seminoma rates remained higher among most other groups.
Hispanic men now have the highest TGCT incidence rates in the United States, although the rates increased among all groups between 1992 and 2021. Racial/ethnic differences in rates require further investigation.
睾丸生殖细胞肿瘤(TGCTs)是美国年轻男性中最常见的癌症。历史上,非西班牙裔白人(NHW)男性的发病率一直远高于其他男性。为研究这种模式是否发生了变化,作者考察了1992年至2021年TGCT发病率的趋势。
利用监测、流行病学和最终结果12个登记处数据库,计算了总体以及按组织学类型(精原细胞瘤和非精原细胞瘤)、年龄、诊断时分期和种族/族裔划分的每10万人年的年龄标准化发病率及95%置信区间(CIs)。还考察了5年生存率的趋势。
每10万人年的TGCT年龄标准化发病率从1992年的4.71(95%CI,4.39 - 5.05)增至2021年的6.22(95%CI,5.88 - 6.58)。精原细胞瘤(平均年变化百分比[AAPC],0.57%;95%CI,0.40% - 0.75%)和非精原细胞瘤(AAPC,1.41%;95%CI,1.17% - 1.64%)的发病率均有所上升,且所有种族/族裔群体的发病率都上升了,不过NHW男性的发病率趋于稳定。西班牙裔男性的发病率增幅最大(AAPC,3.03%;95%CI,2.66% - 3.40%),他们的诊断中位年龄是最年轻的之一,与NHW男性相比,更有可能在晚期被诊断出来。在研究期间,西班牙裔男性的精原细胞瘤和非精原细胞瘤发病率趋于一致,而在大多数其他群体中,精原细胞瘤发病率仍然较高。
尽管1992年至2021年间所有群体的发病率都有所上升,但西班牙裔男性目前在美国的TGCT发病率最高。发病率的种族/族裔差异需要进一步调查。